Strata Skin Sciences Archives - Medical Design Sourcing

Strata Skin Sciences signs distribution agreement in Mexico

Strata Skin Sciences today announced it signed an exclusive distribution agreement with Mino Labs to commercialize its products in Mexico.

Through the deal, Mino Labs will distribute Strata Skin Sciences’ TheraClear X, VTrac and XTrac in Mexico for three years.

“We are excited to have entered into an exclusive sales agreement with MINO Labs,” Strata Skin Sciences CEO Bob Moccia said in a news release. “With the addition of Mexico, Strata has the potential to access a nearly $300 million market for acne, psoriasis, and vitiligo. Mino’s 20 years of experience in the pharmaceutical industry and deep expertise in the Central and Latin American region, will allow Strata to provide those in Mexico who suffer from skin conditions another treatment option. In particular, there is a high need for acne treatments as 80%1 of the Mexican population is affected by low to severe acne. We look forward to continuing to broaden the reach of our treatment devices and help …

Strata Skin Sciences signs distribution deal in Israel

Strata Skin Sciences this week announced that it signed a distribution agreement with JuvenIL to supply Strata’s Xtrac excimer lasers in Israel.

Israel-based JuvenIL makes dermatology and aesthetic technologies for medical centers across the country. The distribution deal will provide Strata Skin Sciences with a similar distribution network.

“We believe that entering into the Israeli market presents a good opportunity for Strata,” president and CEO Robert Moccia said in a news release. “Following approval to market our products in Israel, we identified JuvenIL as the ideal partner in the region. Through JuvenIL, we can now market our products to the entire Israeli population, of which there are an estimated 300,000 psoriasis and 160,000 vitiligo patients that can benefit from our laser treatment. We are confident that JuvenIL’s experienced team will be invaluable as they work with the more than forty major hospitals and four major Health Maintenance Organ…

MedTech 100 roundup: On the rise again

After a slight hiccup disrupted weeks of improvement, the medtech industry again flexed its muscles over the last seven days.

MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 20) at 119.63 points, representing a 1.5% rise from the 117.92-point tally set a week prior.

The shift marks a quick rebound from the -1.2% dip observed in the previous week and the index now sits at its highest week-ending mark ever, having actually hit an all-time best of 119.72 points on Aug. 17.

Medtech’s performance continues to reflect an overall rebound from the struggles brought on by the COVID-19 pandemic, too. The industry remains well above the marks set around the height of the pandemic, having registered a 29.6% increase from the pre-pandemic high of 92.32 (set on Feb. 19, 2020). Moreover, it remains well ahead of the mid-pandemic low of 62.13 (March 23, 2020) as well, totaling an 92.5% asc…

Strata Skin Sciences buys Ra Medical’s Pharos dermatology business

Strata Skin Sciences (NSDQ:SSKN) announced that it acquired the Pharos dermatology business from Ra Medical (NYSE:RMED).

Horsham, Pa.-based Strata can now market its full business solution to Ra Medical’s existing customer base comprised of 400 dermatology practices, offering opportunities to increase its recurring revenue base and a pathway to gain additional placements for its XTRAC excimer laser system, according to a news release.

Ra Medical’s Pharos excimer laser system holds FDA clearance for the treatment of chronic skin diseases, including psoriasis, vitiligo, atopic dermatitis and leukoderma.

Under the acquisition, Strata will acquire Ra Medical’s dermatology business in an asset transaction with an upfront cash payment of approximately $3.7 million for certain assets and the assumption of estimated customer warranty and service agreement liabilities, among other assumed liabilities.

“As we sought opportunities to furthe…

Strata Skin Sciences names new president and CEO

Strata Skin Sciences today said that it has appointed Robert Moccia as president and CEO, effective immediately.

Moccia replaces former president Dolev Rafaeli, who stepped down as president and CEO on Feb. 28.

“We are delighted to welcome Bob to the Strata team. He is a leader in the field of dermatology, and we are confident that his extensive executive management experience, spanning more than three decades in healthcare, predominantly in the dermatology sector, will deliver a seamless transition,” chairperson Uri Geiger said in a news release. “Looking forward, we believe his proven track record leading and building PE-backed dermatology growth companies, combined with a broad operational skillset, will prove to be an asset as we work towards delivering meaningful value to STRATA’s customers, patients and shareholders.”

Prior to joining the company, Moccia served as president, CEO and cofounder of Encore Dermatology. He has also been CEO of Precision…